Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. - Wikidata - awgldk - TriplyDB

Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.

Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.

http://www.wikidata.org/entity/Q40087698

about

Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domain Siglecs as sensors of self in innate and adaptive immune responses Glycan microarrays for decoding the glycome.Advances in the biology and chemistry of sialic acids.In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.Siglec-mediated regulation of immune cell function in disease.Multivalent ligands for siglecs.Characterizing the glycome of the mammalian immune system.Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man.KSGal6ST generates galactose-6-O-sulfate in high endothelial venules but does not contribute to L-selectin-dependent lymphocyte homing.Leukocyte Trafficking to the Small Intestine and Colon Sialic acids and autoimmune disease.Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.Efficient Mapping of Sulfated Glycotopes by Negative Ion Mode nanoLC-MS/MS-Based Sulfoglycomic Analysis of Permethylated Glycans Natural ligands for CD33-related Siglecs?Basic and clinical immunology of Siglecs Siglecs as targets for therapy in immune-cell-mediated disease.CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers.Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid.Significance of NF-kappaB/GATA axis in tumor necrosis factor-alpha-induced expression of 6-sulfated cell recognition glycans in human T-lymphocytes.Combinatorial chemoenzymatic synthesis and high-throughput screening of sialosides.Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy Concerted mass spectrometry-based glycomic approach for precision mapping of sulfo sialylated N-glycans on human peripheral blood mononuclear cells and lymphocytes.CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity

P2860

Q24293019-50FD9683-B586-4B92-9CC3-CC6F3A82013B Q26829757-56DE155E-71F4-4894-B22A-97C862A1F146 Q31004845-B7306922-85FC-4CF2-887B-C57727A97D82 Q33519629-E9BEC74E-7B6C-4097-862D-267F0F8CE5BB Q33883072-F27DEA9B-B67F-4243-AD41-9B1C0BD3B96C Q34314957-30B5CBB2-A2C3-4C05-B476-BC5B88CC475A Q34449574-5EA62FE8-C99B-44AA-8605-865DD1D9EFC3 Q34813256-187A558D-140D-4256-8C8F-1E31A552BE7C Q36444166-AEE33C1D-7F08-4FE0-A61E-63C90A00BB56 Q36563888-067A0058-DB9B-45B2-804D-787695FB7CA4 Q36592984-7C3A6752-1B3C-42DF-8DE0-2E502C4B122E Q36625410-B76EBB1A-CC07-49AF-8DD6-C9AC0FCF6ABF Q36655884-E6C7D304-15A0-47ED-9021-45AF30305285 Q36832323-AFB95C16-7B77-4A15-BD5A-9218D7D2224B Q37248245-60D1DEB9-283C-4A36-919B-6ACAF8443750 Q37348437-91329E3C-6BD9-4A1F-A7B9-07961076FFD7 Q37440061-50896DA0-20B0-4F87-A255-DB9DC6A2765E Q38227144-36FA626D-C98C-4BE5-A87F-A911BD641DEB Q38332313-8420F944-99A1-4F2F-A916-FDBC15344131 Q38446053-938B0427-25F6-4FE0-865A-6A4256F2EF38 Q39250748-50D30AD7-0938-48B8-A0C7-59A2DBF97422 Q40455985-77E4ED45-5604-4332-8414-2B821DA634A5 Q41601320-A4F66214-46C8-4556-AB9A-DA7486DB55A0 Q42374807-DFE0D793-950C-4654-B00C-1964E38059A1 Q52448825-B6CB725F-8D8B-4FB2-8847-895CE679ADB7 Q57490095-4F60639B-45FD-4081-AE91-A21A09BCB5B6

P2860

Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.

http://www.wikidata.org/entity/Q40087698

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Human B-lymphocytes express al ...... rred ligand for CD22/Siglec-2.

@en

type

label

Human B-lymphocytes express al ...... rred ligand for CD22/Siglec-2.

@en

prefLabel

Human B-lymphocytes express al ...... rred ligand for CD22/Siglec-2.

@en

P1433

Q40087698-BFC95711-7569-49AB-8DF3-217745CCE925

P1476

Q40087698-725E1CD3-C2A1-47F2-A776-80A293F19489

P2093

Q40087698-1CA101A4-0D54-4FBD-B945-CB96EF04F8B9

Q40087698-4CF21E9F-96DF-4FE7-A4EB-13C0909FAABB

Q40087698-52439C7C-E1C8-4F44-AED0-3EC78BE5FF4F

Q40087698-6514DF8F-A632-4BDF-AE46-2731385CBE86

Q40087698-6A0690F9-2968-46ED-893D-37C2E3BD1F68

Q40087698-7F42C622-AECF-4E9C-BA11-DC077935A59C

Q40087698-8664521D-43D7-4B26-9F4E-5AB4B3143975

Q40087698-A6651A57-8D12-4F67-9680-C9233141A00B

Q40087698-C3E07716-1C8D-4D6A-A337-67F694A4730E

Q40087698-E441B7F8-8AF6-40B2-BEDB-79D032A6486D

P2860

Q40087698-037FEDAE-6748-48DE-B956-9301D6571734

Q40087698-0744D786-3877-4A6F-844A-79B1330919C1

Q40087698-126700AE-8ECE-4DB0-A3F3-982950167028

Q40087698-14B4DD3A-4169-44F2-8C1E-E0731A632510

Q40087698-15882148-4D9B-4D12-A74E-EF5F0BED0CB2

Q40087698-29AC1DD5-44EF-48A8-AA65-1FD5D930758E

Q40087698-2A2FBFFD-583B-4DA4-9C32-2F7ADBA44438

Q40087698-306F2FA2-F9A5-45BA-A6EB-4C10C2AC1D1E

Q40087698-377A1F66-9AF2-459A-B406-004AD82CF401

Q40087698-388F6C63-3CC2-4D12-ACF7-A375DA5D76C4

P304

Q40087698-D3B41FBE-B460-427F-8A7D-0E0D34CAD99B

P31

Q40087698-86C0A132-2AFA-4EAB-88E1-ABC0E22F6558

P356

Q40087698-369E9660-5A2C-4787-BF37-2528B0FFDE89

P407

Q40087698-2D0C67E1-523F-47EA-841D-2E4DC414BA2A

P433

Q40087698-08D8E674-F7C6-45C0-BBAE-E133E4CE5D9F

P478

Q40087698-26641089-C2D3-4AA8-A29D-134B13F0B1E9

P577

Q40087698-EA36F11A-18C4-4348-952A-DDDF1633B8D6

P698

Q40087698-A94AE875-A16A-44B1-8CDB-6A3E9B3DEE0A

P356

P1433

Journal of Biological Chemistry

P1476

Human B-lymphocytes express al ...... rred ligand for CD22/Siglec-2.

@en

P2093

Akihiko Moriyama

http://www.w3.org/2001/XMLSchema#string

Hiromu Takematsu

http://www.w3.org/2001/XMLSchema#string

Katsuyuki Ohmori

http://www.w3.org/2001/XMLSchema#string

Keiko Miyazaki

http://www.w3.org/2001/XMLSchema#string

Mineko Izawa

http://www.w3.org/2001/XMLSchema#string

Naoko Kimura

http://www.w3.org/2001/XMLSchema#string

Reiji Kannagi

http://www.w3.org/2001/XMLSchema#string

Yasunori Kozutsumi

http://www.w3.org/2001/XMLSchema#string

Yosuke Yasuda

http://www.w3.org/2001/XMLSchema#string

Yuji Matsuzaki

http://www.w3.org/2001/XMLSchema#string

P2860

Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin

Human N-acetylglucosamine-6-O-sulfotransferase involved in the biosynthesis of 6-sulfo sialyl Lewis X: molecular cloning, chromosomal mapping, and expression in various organs and tumor cells

A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins

Continuous cultures of fused cells secreting antibody of predefined specificity

Molecular interactions regulate BCR signal inhibition by CD22 and CD72

Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase

Hyperresponsive B cells in CD22-deficient mice

A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP

The molecular basis for the absence of N-glycolylneuraminic acid in humans.

P304

32200-32207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M702341200

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

282

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17728258

http://www.w3.org/2001/XMLSchema#string